InvestorsHub Logo
Followers 827
Posts 119492
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 170

Saturday, 12/05/2015 4:00:38 PM

Saturday, December 05, 2015 4:00:38 PM

Post# of 232
EGRX will launch liquid Angiomax product “at risk” as soon as it receives FDA approval:

#msg-118876127

Curious that MDCO never filed suit against EGRX under the standard Hatch-Waxman procedure.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”